Storyline

Eli Lilly acquires CrossBridge Bio to expand dual-payload ADC pipeline

Eli Lilly has acquired Houston-based CrossBridge Bio in a deal worth up to $300 million to enhance its antibody-drug conjugate (ADC) portfolio.

Current brief openSource links open
This current storyline is open here with summary, metadata, source links, continuity context, and full evidence. Paid is for compare-over-time, alerts, exports, and workflow.
No card needed for the free brief.
Evidence trail (top sources)
top sources (2 domains)domains are deduped. counts indicate coverage, not truth.
2 top sources shown
BioPharma Dive
biopharmadive.com · biopharmadive.com · 2026-04-14 14:20 UTC
limited source diversity in top sources
Overview

Eli Lilly has acquired Houston-based CrossBridge Bio in a deal worth up to $300 million to enhance its antibody-drug conjugate (ADC) portfolio.

Score total
1.58
Momentum 24h
3
Posts
3
Origins
3
Source types
2
Duplicate ratio
0%
Why now
  • CrossBridge's lead candidate is poised to enter clinical trials this year, making timely integration critical.
  • The $300 million deal reflects Lilly's strategic focus on expanding its oncology pipeline.
  • The acquisition follows recent funding and development milestones at CrossBridge Bio.
Why it matters
  • Dual-payload ADCs represent an advanced approach to targeting cancer with improved efficacy.
  • Lilly's acquisition accelerates clinical development of innovative oncology therapies.
  • CrossBridge's technology originated from academic research, highlighting translational biotech innovation.
Continuity snapshot
  • Trend status: insufficient_history.
  • Continuity stage: emerging_confirmed.
  • Current status: open.
  • 3 current source-linked posts are attached to this storyline.
All evidence
Show filters & breakdown
Posts loaded: 0Publishers: 3Origin domains: 3Duplicates: -
Showing 3 / 0
Top publishers (this list)
  • biopharmadive.com (1)
  • Fierce Biotech (1)
  • biotech (1)
Top origin domains (this list)
  • biopharmadive.com (1)
  • fiercebiotech.com (1)
  • reddit.com (1)